| Register
| Log out
Submit An Article

josh fegan

Latest Articles

  • Cannabis stocks rise as TGA to approve over-the-counter CBD without prescription

    Cannabis stocks rise as TGA to approve over-the-counter CBD without prescription

    Despite a gloomy day on the ASX yesterday, Australian cannabis companies ended it very well upon news of the Therapeutic Goods Association (TGA) announcing they will amend legislation that will open a clear path for Australians to purchase cannabidiol (CBD) products without a prescription.  The notice of interim decision was released confirming that the TGA

    Read More
    Public
  • Althea’s cannabis clinics join national referrals network, telehealth booming

    Althea’s cannabis clinics join national referrals network, telehealth booming

    Global pharmaceutics and cannabis healthcare company Althea Group (ASX: AGH) has harnessed the power of telehealth through COVID-19, almost doubling web-based enquiries for their MyAccess Clinics in the UK where patients can seek medicinal cannabis treatment pathways.  With the England being one of the harder nations hit by COVID-19, Althea accelerated telehealth offerings for its

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.